1. To establish whether antihypertensive medication reduction is possible without significant changes in systolic blood pressure control or adverse events during 12 week follow up.
2. To determine clinical significance of study results.
05/07/2021 - 12:00pm to 1:00pm CDT
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Mohammed Nasaruddin, MD